0001209191-15-046721.txt : 20150526
0001209191-15-046721.hdr.sgml : 20150525
20150526164035
ACCESSION NUMBER: 0001209191-15-046721
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150522
FILED AS OF DATE: 20150526
DATE AS OF CHANGE: 20150526
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Karyopharm Therapeutics Inc.
CENTRAL INDEX KEY: 0001503802
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263931704
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 85 WELLS AVENUE
STREET 2: SECOND FLOOR
CITY: NEWTON
STATE: MA
ZIP: 02459
BUSINESS PHONE: 617-658-0600
MAIL ADDRESS:
STREET 1: 85 WELLS AVENUE
STREET 2: SECOND FLOOR
CITY: NEWTON
STATE: MA
ZIP: 02459
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dolsten Mikael
CENTRAL INDEX KEY: 0001437590
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36167
FILM NUMBER: 15889854
MAIL ADDRESS:
STREET 1: 5 GIRALDA FARMS
CITY: MADISON
STATE: NJ
ZIP: 07940
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-05-22
0
0001503802
Karyopharm Therapeutics Inc.
KPTI
0001437590
Dolsten Mikael
C/O KARYOPHARM THERAPEUTICS INC.
85 WELLS AVENUE
NEWTON
MA
02459
1
0
0
0
Nonstatutory Stock Option (right to buy)
26.15
2015-05-22
4
A
0
10000
0.00
A
2025-05-21
Common Stock
10000
10000
D
This option vests as to 100% of the underlying shares on May 22, 2016, provided that the holder continues to serve as a director of the issuer through such date.
/s/Christopher B. Primiano, Attorney-in-Fact for Mikael Dolsten
2015-05-26